Literature DB >> 19858300

Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates.

Sameera Sayeed1, Jihong Li, Bruce A McClane.   

Abstract

The important veterinary pathogen Clostridium perfringens type B is unique for producing the two most lethal C. perfringens toxins, i.e., epsilon-toxin and beta-toxin. Our recent study (K. Miyamoto, J. Li, S. Sayeed, S. Akimoto, and B. A. McClane, J. Bacteriol. 190:7178-7188, 2008) showed that most, if not all, type B isolates carry a 65-kb epsilon-toxin-encoding plasmid. However, this epsilon-toxin plasmid did not possess the cpb gene encoding beta-toxin, suggesting that type B isolates carry at least one additional virulence plasmid. Therefore, the current study used Southern blotting of pulsed-field gels to localize the cpb gene to approximately 90-kb plasmids in most type B isolates, although a few isolates carried a approximately 65-kb cpb plasmid distinct from their etx plasmid. Overlapping PCR analysis then showed that the gene encoding the recently discovered TpeL toxin is located approximately 3 kb downstream of the plasmid-borne cpb gene. As shown earlier for their epsilon-toxin-encoding plasmids, the beta-toxin-encoding plasmids of type B isolates were found to carry a tcp locus, suggesting that they are conjugative. Additionally, IS1151-like sequences were identified upstream of the cpb gene in type B isolates. These IS1151-like sequences may mobilize the cpb gene based upon detection of possible cpb-containing circular transposition intermediates. Most type B isolates also possessed a third virulence plasmid that carries genes encoding urease and lambda-toxin. Collectively, these findings suggest that type B isolates are among the most plasmid dependent of all C. perfringens isolates for virulence, as they usually carry three potential virulence plasmids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858300      PMCID: PMC2798229          DOI: 10.1128/IAI.00838-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Clostridium perfringens: toxinotype and genotype.

Authors:  L Petit; M Gibert; M R Popoff
Journal:  Trends Microbiol       Date:  1999-03       Impact factor: 17.079

2.  Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene.

Authors:  Derek J Fisher; Kazuaki Miyamoto; Benjamin Harrison; Shigero Akimoto; Mahfuzur R Sarker; Bruce A McClane
Journal:  Mol Microbiol       Date:  2005-05       Impact factor: 3.501

3.  The Clostridium perfringens enterotoxin gene is on a transposable element in type A human food poisoning strains.

Authors:  Sigrid Brynestad; Bjørnar Synstad; Per Einar Granum
Journal:  Microbiology (Reading)       Date:  1997-07       Impact factor: 2.777

4.  Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens.

Authors:  Trudi L Bannam; Wee Lin Teng; Dieter Bulach; Dena Lyras; Julian I Rood
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

5.  Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates.

Authors:  Kazuaki Miyamoto; Derek J Fisher; Jihong Li; Sameera Sayeed; Shigeru Akimoto; Bruce A McClane
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

6.  Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases.

Authors:  R E Collie; B A McClane
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  Beta2 toxin, a novel toxin produced by Clostridium perfringens.

Authors:  M Gibert; C Jolivet-Reynaud; M R Popoff; C Jolivet-Renaud
Journal:  Gene       Date:  1997-12-05       Impact factor: 3.688

8.  Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences.

Authors:  S J Billington; E U Wieckowski; M R Sarker; D Bueschel; J G Songer; B A McClane
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease.

Authors:  F Jin; O Matsushita; S Katayama; S Jin; C Matsushita; J Minami; A Okabe
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Evidence that Tn5565, which includes the enterotoxin gene in Clostridium perfringens, can have a circular form which may be a transposition intermediate.

Authors:  S Brynestad; P E Granum
Journal:  FEMS Microbiol Lett       Date:  1999-01-01       Impact factor: 2.742

View more
  30 in total

Review 1.  Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections.

Authors:  F A Uzal; B A McClane
Journal:  Vet Microbiol       Date:  2011-02-26       Impact factor: 3.293

2.  Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.

Authors:  James R Theoret; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 3.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 4.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

5.  Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

6.  Clinico-pathological findings of Clostridium perfringens type D enterotoxaemia in goats and its hemolytic activity in different erythrocytes.

Authors:  A Ali Nasir; M Younus; A Rashid; S Abdul Khaliq; E Khan; S H Shah; A Aslam; M A Ghumman; M H Joiya
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

7.  Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany.

Authors:  Menglin Ma; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

8.  Organization of the cpe locus in CPE-positive clostridium perfringens type C and D isolates.

Authors:  Jihong Li; Kazuaki Miyamoto; Sameera Sayeed; Bruce A McClane
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Identification of novel pathogenicity loci in Clostridium perfringens strains that cause avian necrotic enteritis.

Authors:  Dion Lepp; Bryan Roxas; Valeria R Parreira; Pradeep R Marri; Everett L Rosey; Joshua Gong; J Glenn Songer; Gayatri Vedantam; John F Prescott
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.

Authors:  Justine M Harkness; Jihong Li; Bruce A McClane
Journal:  Anaerobe       Date:  2012-09-11       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.